Relationship between Helicobacter pylori Eradication and Barrett’s Esophagus Elongation
Digestion · 2024
DOI: 10.1159/000536443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, 2024. Verfasst von Kenta Hashigami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan. Hauptthemen laut MEDLINE: Barrett Esophagus, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Helicobacter pylori eradication therapy may worsen gastroesophageal reflux disease that is a significant risk factor for Barrett’s esophagus. However, the relationship between eradication therapy and Barrett’s esophagus remains controversial. This study evaluated the impact of Helicobacter pylori eradication on the lengthening of Barrett’s esophagus. Materials and Methods: We conducted a retrospective analysis of consecutive patients who successfully underwent Helicobacter pylori eradication between 2004 and 2017. Endoscopic images obtained before and after eradication therapy were compared for Barrett’s esophagus length according to the Prague C&M criteria and the presence of reflux esophagitis based on the Los Angeles classification.
Results
A total of 340 patients were analyzed (mean age: 66.9 ± 12.9 years) for a median follow-up of 55 months (interquartile range: 29.8–89.3). At the initial endoscopic assessment, 187 patients (55%) had a hiatal hernia, and all patients had gastric atrophy (C-0 to I: 2%, C-II to III: 47%, O-I to III: 51%). Reflux esophagitis was detected in 7 patients (2%) before eradication and in 21 patients (6%) afterward, which was a significant increase (p = 0.007). Barrett’s esophagus was identified in 69 patients (20%) before eradication, with a median length of C0M1. Elongation after treatment was observed in only 2 patients (0.6%). We observed no significant increase in either the prevalence (p = 0.85) or the median length (p = 0.5) of Barrett’s esophagus.
Conclusions
Only 0.6% of patients exhibited Barrett’s esophagus lengthening after Helicobacter pylori eradication therapy, suggesting no significant impact of the treatment on the development or elongation of Barrett’s esophagus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan.
- Endoscopic Examination Center, Shinshu University Hospital, Matsumoto, Japan.
- Endoscopy Center, Nagano Prefectural Shinshu Medical Center, Matsumoto, Japan.
- Department of Advanced Therapeutic Endoscopy, Shinshu University School of Medicine, Matsumoto, Japan.
Zitieren
APA
Hashigami, K., Iwaya, Y., Nagaya, T., Hara, D., Hirayama, A., Okamura, T., Akamatsu, T., & Umemura, T. (2024). Relationship between Helicobacter pylori Eradication and Barrett’s Esophagus Elongation. Digestion. https://doi.org/10.1159/000536443
Vancouver
Hashigami K, Iwaya Y, Nagaya T, Hara D, Hirayama A, Okamura T, et al. Relationship between Helicobacter pylori Eradication and Barrett’s Esophagus Elongation. Digestion. 2024. doi:10.1159/000536443
BibTeX
@article{Hashigami2024,
author = {Hashigami, Kenta and Iwaya, Yugo and Nagaya, Tadanobu and Hara, Daichi and Hirayama, Atsuhiro and Okamura, Takuma and Akamatsu, Taiji and Umemura, Takeji},
title = {Relationship between Helicobacter pylori Eradication and Barrett’s Esophagus Elongation},
journal = {Digestion},
year = {2024},
doi = {10.1159/000536443}
}
EUVIMED